REVBIO, INC.
Tetranite® Adhesive Dental Bone Scaffold (ADBS), a mineral-organic biomaterial drug delivery device that fills extraction sites and releases local anesthetic (bupivacaine) to manage post-operative den
- Sector
- Medtech
- Headquarters
- Lowell, MA
- Founded
- 2016
- Latest Form D
- $187K, May 2023
- Total capital
- $31.3M
- Federal grants
- $17.4M
- 14 awards · 2018–2025
- Rank in peer group#15 of 538
- Private capital raised
- $13.9M
- 3 Form D · last May 2023
- 41 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 27 pending · first 2022
- Rank in peer group#111 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Improved Treatment Options for Vertebral Compression Fractures in Elderly Patients Using Minimally Invasive, Image-Guided Delivery of a Regenerative Bone Adhesive$2M
- Federal grantHealth and Human S · Phase II · A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported Outcomes$715K
- Federal grantHealth and Human S · Phase II · A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported Outcomes$1.7M
- Federal grantHealth and Human S · Phase II · Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption$730K
- Federal grantHealth and Human S · Phase II · Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging Patients$1.7M
- Federal grantHealth and Human S · Phase II · A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures$2.1M
- Federal grantHealth and Human S · Phase II · Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption$1.3M
- Private capital raisedForm D · SEC · 3rd filing$187K
- Private capital raisedForm D · SEC · 2nd filing$5.2M
- Private capital raisedForm D · SEC · 1st filing$8.5M
Show 7 earlier federal awards
- Federal grantHealth and Human S · Phase I · Improved Treatment of Vertebral Compression Fractures for Elderly Patients Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive$375K
- Federal grantHealth and Human S · Phase II · Improved Treatment of Distal Radius Fractures Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive$625K
- Federal grantHealth and Human S · Phase II · A Novel Bioresorbable Bone Adhesive Used to Fixate Cranial Flaps and Reduce Infection Rates$1.2M
- Federal grantHealth and Human S · Phase II · Improved Treatment of Distal Radius Fractures Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive$2M
- Federal grantHealth and Human S · Phase II · A Novel Bioresorbable Bone Adhesive Used to Fixate Cranial Flaps and Reduce Infection Rates$2.5M
- Federal grantHealth and Human S · Phase I · A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures$300K
- Federal grantHealth and Human S · Phase I · Formation and Structural Property Relationships of a Tetracalcium Phosphate Bone Adhesive Biomaterial$197K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
9months
from REVBIO, INC.’s first federal award to its first private round.
- First federal award · Apr 2018
- Health and Human S · $197K
- First Form D · Jan 2019
- $8.5M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#15 · top 3%
- Granted patents#111 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- BRIAN HESSResearcherExecutive Officer, DirectorLinked by 3 patents · $11M in grants as PI
- D. GRAYSON ALLENExecutive Officer, DirectorNamed in SEC Form D filings
- GEORGE KAYDirectorNamed in SEC Form D filings
- KEVIN GRAYSON FOLEYDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 32- PendingAdhesive Compositions With Tunable Porosity And Acidity Content And Methods Of Use ThereofUSPTOApplication 19099185
- PendingCompositions And Methods For Adhesion To SurfacesUSPTOApplication 18949382
- PendingCompositions And Methods For Adhesion To SurfacesUSPTOApplication 18665143
Show all 32 patent records
- Adhesive Compositions With Tunable Porosity And Acidity Content And Methods Of Use ThereofFeb 12, 2026 · Application 19099185Pending
- Compositions And Methods For Adhesion To SurfacesJul 10, 2025 · Application 18949382Pending
- Compositions And Methods For Adhesion To SurfacesApr 17, 2025 · Application 18665143Pending
- Devices And Methods For Bone FixationFeb 13, 2025 · Application 18717801Pending
- Compositions And Methods For Adhesion To SurfacesDec 31, 2024 · US 12,178,937Granted
- Compositions And Methods For Adhesion To SurfacesOct 22, 2024 · US 12,122,717Granted
- Image Guided Delivery Of Compositions And Related MethodsJun 6, 2024 · Application 18283642Pending
- Bone Flap Fixation DeviceOct 19, 2023 · Application 18010603Pending
- Implantable Objects, Guiding Devices, And Methods Of Use ThereofSep 19, 2023 · US 11,759,546Granted
- Compositions And Methods For Adhesion To SurfacesJul 6, 2023 · Application 17992527Pending
- Implantable Objects, Guiding Devices, And Methods Of Use ThereofMay 18, 2023 · Application 17847894Pending
- Compositions And Methods For Adhesion To SurfacesMay 2, 2023 · US 11,638,777Granted
- Adhesive Compositions Comprising TherapeuticsDec 22, 2022 · Application 17774409Pending
- Formulation And Packaging Of CompositionsOct 20, 2022 · Application 17639221Pending
- Compositions And Methods For Adhesion To SurfacesFeb 15, 2022 · US 11,247,941Granted
- Compositions And Methods For Regeneration Of Bone TissueJan 27, 2022 · Application 17221339Pending
- Devices And Compositions And Methods Of Use ThereofJan 24, 2019 · Application 16069826Pending
- Compositions And Methods For Adhesion To SurfacesMar 29, 2018 · Application 15577067Pending
- Image Guided Delivery Of Compositions And Related MethodsApplication 63164703Pending
- Bone Flap Fixation DeviceApplication PCTUS2021037466Pending
- Devices And Methods For Bone FixationApplication 63411408Pending
- Adhesive Compositions Comprising TherapeuticsApplication PCTUS2020058945Pending
- Formulation And Packaging Of CompositionsApplication PCTUS2020048584Pending
- Bone Flap Fixation DeviceApplication 63039306Pending
- Adhesive Compositions Comprising TherapeuticsApplication 62930467Pending
- Devices And Methods For Bone FixationApplication 63289927Pending
- Compositions And Methods For Regeneration Of Bone TissueApplication 15771831Pending
- Bone Flap Fixation DeviceApplication 63114920Pending
- Ph Tunable Adhesive Compostions And Methods Of Use ThereofApplication 63369690Pending
- Devices And Methods For Bone FixationApplication PCTUS2022053088Pending
- Adhesive Compositions With Tunable Porosity And Acidity Content And Methods Of Use ThereofApplication PCTUS2023029031Pending
- Image Guided Delivery Of Compositions And Related MethodsApplication PCTUS2022021568Pending
Related companies, and why
- HELIXBIND, INC.Similar federal contract value in Medtech · null in contracts
- HARMONUS, INC.Similar federal contract value in Medtech · null in contracts
- EARLY IS GOOD INC.Similar federal contract value in Medtech · null in contracts
- ENDOMEDIX, INC.Similar federal contract value in Medtech · null in contracts
- PHAST CORPSimilar federal contract value in Medtech · null in contracts
- SCION NEUROSTIM, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .